Acurx Pharmaceuticals (ACXP) Tops Q1 EPS by 2c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance